Navigation Links
Positron And Biologics Modular Enter Into Co-Marketing Agreement
Date:5/3/2013

lows our customers to control initial capital expenditures and ongoing operating costs better than their competition."

About Positron: Positron Corporation is a nuclear medicine healthcare company vertically integrating key segments of nuclear cardiology—providing an end-to-end solution for cardiac PET.  Through proprietary PET imaging systems, radiopharmaceuticals and radioisotopes solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes, while practicing cost effective medicine. Positron's unique products, market position and approach in securing the supply chain are substantial advantages, further accelerating the adoption of cardiac PET and growth of nuclear cardiology.  Positron is redefining the industry.  More information about Positron is available at www.positron.com.

About Biologics Modular:  Biologics Modular designs, manufactures, and sells modular facilities to serve as self-contained biorepositories, biomanufacturing suites, and research suites to health science service providers, educational facilities, and pharmaceutical manufacturers. For more information, please visit www.biologicsmodular.com.

Forward Looking Statements:  Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Positron assumes no obligation
'/>"/>

SOURCE Positron Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positron Consolidates Radiopharmaceutical & Radioisotope Facilities
2. Positrons Attrius PET Scanner Now Utilized In Alzheimers Imaging With Amyvid Agent
3. Neusoft Positron Medical Systems Receives ISO Certification and CE Mark for their Attrius PET System
4. Positron Appoints Charles Conroy As Chief Operating Officer
5. Positron Introduces Next Generation PosiRx Pharmacy Automation Systems
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
8. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
9. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
10. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
11. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... on Thursday, August 7, 2014 before markets open. The ... conference call at 8:00 a.m. Eastern time (5:00 a.m. ... call and webcast to discuss financial results and recent ... calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant ...
(Date:7/31/2014)... Cipla Europe NV ("Cipla") ... entered into a commercial collaboration, covering the territory ... countries, for BioQuiddity,s OneDose ReadyfusOR™ in regional anesthetic ... launch the CE Marked OneDose ReadyfusOR pre-filled with ... market late this year. The ready-to-use infusion systems ...
(Date:7/31/2014)... and NOTTINGHAM, England , July ... CBRX ) today announced that its ... announced a collaboration that will support pharmaceutical and ... development stage.  Molecular Profiles, pharmaceutical development services will ... metabolism and pharmacokinetics (DMPK) to give clients a ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 2Cipla and BioQuiddity Announce EU Commercial Partnership for OneDose-ReadyfusOR for Post-Surgical Pain Management 3Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3
(Date:7/31/2014)... HealthDay Reporter , WEDNESDAY, ... electronic cigarettes isn,t warranted based on current evidence, a ... e-cigarettes to compete with regular cigarettes might cut tobacco-related ... prior studies on the use and safety of the ... there is a potential for smokers to reduce their ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... to reach $702m by 2020, increasing slowly ... market will be driven by: the rising ... incurred by government agencies, such as Medicare, ... adoption of innovative technologies such as flow ...
(Date:7/31/2014)... fun for anyone, but for those with periodontal disease related ... them smiling. In a report appearing in the August 2014 ... , one of the most important blood cells involved in ... inflammation and bone loss in type 2 diabetes-associated periodontal disease. ... the responses of B cells may treat or prevent this ...
(Date:7/31/2014)... WI (PRWEB) July 31, 2014 Quincy ... creators of brain health supplement Prevagen®, releases the second ... 10 Marvelous Tips for Making Memories: Birth of a ... resource that offers exceptional memory-making tips and ideas for ... the birth of a grandchild. Each concept published in ...
(Date:7/31/2014)... During an annual summer didactic and live technique ... plastic surgeon and a member of the faculty ... of facial anatomy and key advances in facial cosmetic ... Meeting of the Cosmetic Bootcamp included lectures, anatomical analysis, ... principles in modern facial surgery. , One of Dr. ...
Breaking Medicine News(10 mins):Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 2Health News:Dr. Rod J. Rohrich Demonstrates Advances in Facial Surgery at Annual Cosmetic Surgery Seminar 3
... ... defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. ... Vancouver, BC (PRWEB) ... the release of TeSR™2 , a defined, animal-protein free maintenance medium for human ...
... CARMEL, Ind., Oct. 13 Conseco, Inc. (NYSE: CNO ... to ensure that all investors have equal access to information, ... 5:30 p.m. on Tuesday, October 13, 2009. The materials ... exhibits that Conseco will submit to the Securities Exchange Commission ...
... Porpoise Evans, a litigation associate in the Miami office of ... among the "40 Under 40" outstanding lawyers of Miami-Dade County ... be honored at the CFF benefit dinner on November 20, ... as one of Miami-Dade County,s top up-and-coming young lawyers is ...
... WASHINGTON, Oct. 13 America,s Health Insurance Plans (AHIP) ... today on passage of health care reform legislation in ... bipartisan health care reform that covers all Americans, improves ... affordable, sustainable path. Health plans have proposed guaranteed ...
... the following statement today from Executive Vice President ... approval today of historic health care reform legislation ... coordinated health benefits and quality focused coverage as ... chronically-ill and underserved Medicare recipients." , ...
... more pre-term infants survive, doctors see more babies with ... News) -- Increased survival of extremely pre-term infants has ... problems caused by abnormal development of blood vessels in ... looked at data on 506 extremely pre-term infants (born ...
Cached Medicine News:Health News:STEMCELL Technologies Inc. Announces Release of Defined, Animal-Protein Free Maintenance Medium for hESCs and hiPSCs 2Health News:Conseco Announces Availability of Important Information on its Website 2Health News:Cystic Fibrosis Foundation Names Greenberg Traurig Attorney D. Porpoise Evans Among the '40 Under 40' Outstanding Lawyers of Miami-Dade County 2Health News:AHIP Statement on Passage of Senate Finance Committee Legislation 2Health News:XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 2Health News:Eye Problems Increasing in Preemies 2
... The VitalView™ Central Station is a ... bedside monitors for vital signs monitoring. ... in real time, with simultaneous display ... events, graphical and tabular trends are ...
... The Gemini Family of infusion ... with a collective series of ... product line offers a wide ... IV sets, each featuring the ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
... Infusion System many of its innovations ... as the principles of human factors ... to the creation of a medical ... to reduce errors in operation while ...
Medicine Products: